Follow the CELYAD ONCOLOGY share price and the full insider trade history of the company, a listed issuer based in Belgium. Shares trade on the BE market, under the supervision of FSMA. Operating in the Health Care sector, CELYAD ONCOLOGY has logged 6 reports. Market capitalisation: €11.7m. The latest transaction was reported on 28 November 2024 (Other). Among the most active insiders: Kane Matthew. The full history is openly available.
6
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
19Σ signal
Fundamental score
Ranked 6,007 of 29,064 companies
66.4
score / 100
Value
44
Quality
88
FCF yld-59%
Earn yld7.1%
EV/EBITDA11.0x
ROE56%
Gross mgn62%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.